Neonatal and Pediatric Respiratory Care: A Complete Guide

Neonatal and pediatric respiratory care requires an understanding of how the cardiopulmonary system develops, how newborns transition from fetal to extrauterine life, and how respiratory disease differs throughout infancy and childhood.

Children cannot simply be treated as smaller adults because airway size, chest wall mechanics, metabolic demand, ventilatory control, and pulmonary reserve vary considerably with age and maturity.

Respiratory care therefore combines developmental physiology, careful assessment, monitoring, oxygen therapy, airway management, ventilatory support, pharmacologic treatment, disease-specific interventions, and continuous evaluation of the patient’s response.

Why Respiratory Care Is Different in Infants and Children

The respiratory system changes substantially from premature infancy through adolescence. Neonates and young infants have smaller airways, more compliant chest walls, fewer developed alveoli, and less respiratory reserve than adults. They also consume more oxygen relative to body size, which means respiratory deterioration can occur quickly when ventilation or oxygenation becomes impaired.

Airway diameter is particularly important. Resistance to airflow increases dramatically as airway radius decreases, so a relatively small amount of edema, mucus, inflammation, or bronchoconstriction can produce significant obstruction in an infant or young child. This helps explain why conditions such as croup, bronchiolitis, and airway swelling can become clinically significant very quickly.

The neonatal chest wall is highly compliant because the ribs and supporting structures are less rigid. When the lungs become difficult to inflate, negative intrathoracic pressure may pull the soft chest wall inward, producing visible retractions. Premature infants are especially vulnerable because their lung tissue may also be poorly compliant due to incomplete development and inadequate surfactant.

Other important age-related differences include higher normal respiratory rates, smaller tidal volumes, different drug metabolism, limited ability to cough effectively, and an inability in very young patients to describe symptoms or cooperate with testing. Respiratory equipment, medication delivery systems, airway sizes, oxygen concentrations, and ventilator settings must therefore be selected according to the child’s developmental stage, body size, and underlying physiology.

Fetal Lung Development

Normal neonatal respiratory function depends heavily on events that occur before birth. Fetal lung development progresses through the embryonic, pseudoglandular, canalicular, saccular, and alveolar stages. Each phase contributes to the formation of the airways, pulmonary vasculature, gas-exchange structures, and surfactant system.

Embryonic and Pseudoglandular Development

The embryonic phase begins during the first several weeks after conception. The primitive respiratory system develops as a bud from the foregut and gradually forms the trachea, major bronchi, and early lung structures. The diaphragm also begins to develop during this period. Significant developmental disturbances at this stage may result in major congenital abnormalities involving the lungs, trachea, esophagus, or diaphragm.

During the pseudoglandular period, which continues until approximately 16 weeks of gestation, extensive airway branching occurs. The basic bronchial tree and terminal bronchioles develop, but structures capable of effective pulmonary gas exchange are not yet present.

Note: A fetus delivered during this phase is not viable because the pulmonary capillary network and gas-exchange units have not developed sufficiently to support life outside the uterus.

Canalicular, Saccular, and Alveolar Development

The canalicular period occurs at approximately 17 to 26 weeks of gestation. Pulmonary capillaries increase and move closer to the developing airspaces. Type I and Type II pneumocytes also begin to differentiate.

Type I pneumocytes form the thin alveolar surface through which oxygen and carbon dioxide are exchanged. Type II pneumocytes are responsible for producing pulmonary surfactant.

Near the end of the canalicular phase and during early saccular development, sufficient gas-exchange capability may exist to permit survival with intensive neonatal support. This helps explain why viability becomes possible in extremely premature infants, although significant morbidity remains common at very early gestational ages.

During the saccular stage, terminal airspaces enlarge, their walls become thinner, and pulmonary capillaries become increasingly associated with the gas-exchange surface. Surfactant production also increases.

The alveolar phase begins before birth and continues well into childhood. A newborn possesses only a fraction of the mature number of alveoli. Continued multiplication and enlargement of gas-exchange units allow the lungs to grow along with the child.

Pulmonary Surfactant

Surfactant is produced mainly by Type II pneumocytes and stored in intracellular structures known as lamellar bodies. Its most important function is to decrease surface tension within the alveoli.

Without adequate surfactant, small alveoli tend to collapse during expiration. The lungs become less compliant, greater pressure is needed to reopen collapsed airspaces, and the work of breathing increases significantly.

Note: Surfactant deficiency is a major factor in neonatal respiratory distress syndrome, particularly in premature infants whose Type II cells have not matured sufficiently.

Fetal Lung Fluid and Pulmonary Growth

Before birth, fetal lungs are filled with fluid produced primarily by the pulmonary epithelium. This fluid helps maintain lung expansion and contributes to normal structural development.

Near delivery, fluid production decreases and clearance begins. After birth, remaining fluid is absorbed through the pulmonary capillaries and lymphatic system. Failure to clear this fluid efficiently can contribute to transient tachypnea of the newborn.

Normal lung growth can be impaired by conditions such as:

• Severe or prolonged oligohydramnios
• Congenital diaphragmatic hernia
• Renal abnormalities that reduce amniotic fluid volume
• Premature birth
• Prolonged compression of the fetal thorax
• Certain congenital and endocrine disorders

Note: When lung development is significantly impaired, pulmonary hypoplasia may occur. The severity depends partly on when the disruption occurs because early injury can affect airway branching, while later injury may interfere with pulmonary vascular and alveolar development.

Fetal Circulation and the Transition at Birth

Before birth, the placenta performs gas exchange rather than the fetal lungs. Oxygenated blood travels from the placenta through the umbilical vein and is distributed through a specialized circulatory system containing three major fetal shunts: the ductus venosus, foramen ovale, and ductus arteriosus.

The ductus venosus allows some blood from the umbilical vein to bypass the liver and enter the inferior vena cava. Blood entering the right atrium is preferentially directed across the foramen ovale into the left atrium. It then enters the left ventricle and ascending aorta, providing relatively well-oxygenated blood to the coronary and cerebral circulations.

Pulmonary vascular resistance is high during fetal life because the lungs are fluid-filled, unexpanded, and relatively hypoxic. Only a small percentage of right ventricular output travels through the pulmonary circulation. Most blood entering the pulmonary artery is diverted through the ductus arteriosus into the systemic circulation.

The First Breaths

Birth produces major changes in both respiration and circulation. The first breaths expand the lungs, establish functional residual capacity, increase alveolar oxygen tension, and promote clearance of fetal lung fluid.

Considerable inspiratory effort may initially be required to overcome the surface tension and fluid within the newborn lungs. Once the lungs are aerated, surfactant helps stabilize the alveoli and reduces the pressure required for subsequent breaths.

Pulmonary vascular resistance falls rapidly as the lungs expand and oxygenation improves. Pulmonary blood flow therefore increases substantially.

At the same time, clamping of the umbilical cord removes the low-resistance placental circulation and increases systemic vascular resistance. Increasing left atrial pressure relative to right atrial pressure promotes functional closure of the foramen ovale. Increased arterial oxygen tension and changes in circulating prostaglandins encourage constriction of the ductus arteriosus.

Note: Failure of this normal transition can produce clinically important shunting and hypoxemia.

Persistent Pulmonary Hypertension of the Newborn

Persistent pulmonary hypertension of the newborn (PPHN) occurs when pulmonary vascular resistance remains abnormally elevated after birth. Blood may continue to move from the right side of the circulation to the left through fetal pathways, bypassing the lungs and causing severe hypoxemia.

A difference between preductal and postductal oxygen saturation may suggest ductal-level right-to-left shunting. Preductal saturation is typically obtained from the right hand, while a lower extremity can be used for a postductal measurement.

Echocardiography is used to evaluate pulmonary pressures, cardiac anatomy, ventricular function, and the direction of shunting.

Treatment focuses on improving oxygenation and ventilation, correcting acidosis and metabolic abnormalities, maintaining adequate systemic blood pressure, minimizing unnecessary stimulation, and lowering pulmonary vascular resistance when necessary.

Antenatal Assessment and High-Risk Delivery

Many neonatal respiratory problems can be anticipated before delivery. Maternal and obstetric history therefore provides important information about the infant’s respiratory risk.

Factors associated with neonatal complications include:

• Premature labor or premature rupture of membranes
• Maternal diabetes
• Hypertension and preeclampsia
• Maternal infection
• Smoking, alcohol, or drug exposure
• Abnormal fetal growth
• Placental abnormalities
• Oligohydramnios or polyhydramnios
• Multiple gestation
• Meconium-stained amniotic fluid
• Congenital abnormalities
• Abnormal fetal heart-rate patterns

Maternal diabetes can contribute to fetal macrosomia, congenital abnormalities, metabolic disturbances, and respiratory distress. Hypertension and preeclampsia may reduce uteroplacental blood flow and increase the risk of fetal growth restriction, placental abruption, and premature birth.

Prematurity is one of the most important predictors of neonatal respiratory morbidity. Premature infants are at increased risk for respiratory distress syndrome, apnea, bronchopulmonary dysplasia, intraventricular hemorrhage, infection, necrotizing enterocolitis, and retinopathy of prematurity.

Note: When premature delivery is expected, antenatal corticosteroids may be administered to accelerate fetal maturation and reduce the severity of respiratory complications.

Fetal Assessment

Ultrasonography can evaluate fetal growth, anatomy, position, placental location, amniotic fluid volume, and other indicators of fetal well-being. Additional testing may include nonstress testing, contraction stress testing, biophysical profiling, and invasive assessment when clinically indicated.

Fetal heart-rate patterns also provide valuable information during labor. Early decelerations are generally associated with fetal head compression. Variable decelerations are commonly associated with umbilical cord compression, while late decelerations may indicate uteroplacental insufficiency.

Historically, fetal lung maturity has also been estimated using amniotic fluid measurements such as the lecithin-to-sphingomyelin ratio and the presence of phosphatidylglycerol. These measurements reflect surfactant maturation, although clinical decision-making increasingly relies on gestational age and the overall obstetric situation.

Immediate Assessment of the Newborn

The first minutes following delivery are critical because newborns must establish effective ventilation while undergoing major cardiovascular and metabolic changes.

Initial stabilization focuses on maintaining warmth, positioning the airway, assessing respiratory effort and heart rate, providing stimulation when appropriate, and supporting ventilation when needed.

Preventing hypothermia is particularly important in premature and low-birth-weight infants because cold stress increases oxygen consumption and glucose utilization.

Apgar Score

The Apgar score evaluates five areas:

• Heart rate
• Respiratory effort
• Muscle tone
• Reflex irritability
• Color

Each component is assigned a score of 0, 1, or 2. The assessment is typically performed at 1 and 5 minutes after birth and may be repeated when the infant remains compromised.

The Apgar score describes the newborn’s condition and response to transition, but it does not replace respiratory or cardiovascular assessment. Necessary resuscitation should never be delayed while the score is calculated.

Respiratory Distress

A newborn respiratory assessment includes respiratory rate, chest movement, breath sounds, color, oxygen saturation, heart rate, and work of breathing.

Common signs of neonatal respiratory distress include:

• Tachypnea
• Nasal flaring
• Intercostal, subcostal, or sternal retractions
• Expiratory grunting
• Cyanosis
• Diminished or abnormal breath sounds
• Chest-abdominal asynchrony

Grunting occurs when the infant partially closes the glottis during expiration. This generates positive expiratory pressure and helps preserve end-expiratory lung volume. Retractions are particularly prominent in neonates because the chest wall is highly compliant.

The Silverman-Anderson score can be used to quantify neonatal respiratory distress by evaluating chest movement, retractions, nasal flaring, and expiratory grunting.

Periodic Breathing and Apnea

Periodic breathing consists of brief pauses followed by a return to normal respirations and can occur in premature infants without serious consequences.

Apnea is more concerning. Clinically significant neonatal apnea is generally considered a respiratory pause of approximately 20 seconds or a shorter pause associated with bradycardia, oxygen desaturation, cyanosis, pallor, or decreased muscle tone.

Before apnea is attributed to prematurity, other causes such as infection, hypoxemia, anemia, seizures, metabolic abnormalities, airway obstruction, intracranial injury, and medication effects should be considered.

Pediatric Respiratory Assessment

Respiratory assessment changes as children become older and more capable of describing their symptoms. History remains important at every age.

Useful information includes the onset and duration of symptoms, cough characteristics, wheezing or stridor, exercise tolerance, nighttime symptoms, previous hospitalizations, birth history, allergies, medication use, environmental exposures, family history, and previous respiratory disease.

Observation can reveal important signs before the physical examination begins. Tachypnea, nasal flaring, retractions, head bobbing, cyanosis, abnormal posture, and altered mental status may indicate respiratory compromise.

Note: Head bobbing in an infant reflects excessive use of accessory muscles and is an important sign of increased work of breathing.

Breath Sounds and Airway Findings

Auscultation helps localize respiratory abnormalities. Stridor usually indicates obstruction of the upper or central airway. Inspiratory stridor commonly suggests extrathoracic upper-airway narrowing. Wheezing usually reflects narrowed lower airways and may be heard in asthma, bronchiolitis, or other obstructive disorders.

Crackles may occur with pneumonia, pulmonary edema, retained secretions, atelectasis, or parenchymal lung disease. A localized or unilateral wheeze should raise concern for focal airway obstruction, including foreign-body aspiration.

Digital clubbing may suggest chronic disease such as cystic fibrosis, chronic hypoxemia, or certain congenital cardiac disorders. Poor weight gain and failure to thrive can also be important findings in children with chronic respiratory disease.

Monitoring Oxygenation and Ventilation

No single monitoring device provides a complete picture of respiratory function. Clinical assessment must be combined with objective measurements.

Pulse Oximetry

Pulse oximetry continuously estimates arterial oxygen saturation. It is valuable for recognizing hypoxemia and monitoring oxygen therapy, but it does not directly measure ventilation.

A child receiving supplemental oxygen can maintain an acceptable SpO₂ despite significant carbon dioxide retention. Pulse oximetry therefore cannot substitute for evaluation of ventilation when respiratory failure is suspected.

Movement, poor perfusion, incorrect probe placement, ambient light, and other technical factors can also interfere with accuracy.

Capnography

Capnography measures exhaled carbon dioxide and provides information about ventilation, respiratory rate, airway patency, pulmonary perfusion, and endotracheal tube placement.

Changes in the capnogram may reveal hypoventilation, hyperventilation, airway obstruction, disconnection, or changes in circulation before other signs become obvious.

Blood Gas and Transcutaneous Monitoring

Blood gas analysis directly assesses acid-base status, oxygenation, and ventilation. Arterial blood gases provide the most complete information in critically ill patients, while capillary and venous samples can be useful for selected measurements when their limitations are understood.

Transcutaneous oxygen and carbon dioxide monitoring can provide continuous trends, particularly in neonatal care. Measurements should be correlated with blood gas values when therapy depends on precise oxygen or carbon dioxide levels.

Oxygen Therapy

Oxygen therapy is primarily used to correct hypoxemia. Delivery systems for infants and children include nasal cannulas, masks, oxygen hoods, air-entrainment systems, and heated high-flow nasal cannulas.

The appropriate system depends on age, respiratory pattern, oxygen requirement, severity of disease, and tolerance of the interface.

Although oxygen can be lifesaving, excessive exposure can cause injury. Premature infants are particularly susceptible to oxidative damage affecting the lungs and retina. Oxygen should therefore be titrated to the lowest concentration that provides adequate tissue oxygenation rather than administered unnecessarily at high concentrations.

Aerosol Therapy and Pediatric Pharmacology

Delivering aerosol medications to children can be difficult because deposition depends on both the device and the patient’s anatomy and breathing pattern.

Young children have small tidal volumes, rapid respiratory rates, narrow airways, and limited ability to coordinate inhalation. Infants are also primarily nasal breathers, and a substantial portion of an aerosol dose may deposit in the upper airway, face, delivery device, or gastrointestinal tract instead of reaching the lungs.

Crying and agitation can markedly reduce pulmonary deposition because the breathing pattern becomes irregular and leaks around a facemask become more likely.

Common aerosol devices include nebulizers, pressurized metered-dose inhalers, valved holding chambers, facemasks, mouthpieces, and dry powder inhalers.

Young children often benefit from a metered-dose inhaler attached to an appropriately sized valved holding chamber and mask. Older children who can form a seal and follow instructions may use a mouthpiece. Dry powder inhalers require sufficient inspiratory flow and are therefore generally more appropriate for cooperative older children.

Pediatric medication dosing should not automatically be derived by simply reducing an adult dose. Drug distribution, metabolism, pulmonary deposition, body size, disease severity, and the therapeutic response all need to be considered.

Respiratory medications used in children may include bronchodilators, anticholinergic agents, corticosteroids, leukotriene modifiers, mucolytic and hydrating agents, antibiotics, pulmonary vasodilators, and other disease-specific therapies.

Airway Clearance and Airway Management

Airway clearance is indicated when mucus production exceeds the patient’s ability to mobilize and expectorate secretions. Techniques may include positioning, percussion, vibration, assisted cough, positive-pressure devices, high-frequency chest wall therapy, and other mechanical methods.

Therapy should be based on a clinical indication rather than applied routinely to every child with respiratory disease.

Pediatric airway management requires particular attention to airway size. Small amounts of edema, mucus, or narrowing can significantly increase airway resistance.

Endotracheal intubation may be necessary for respiratory failure, severe airway obstruction, apnea, inability to protect the airway, surgical procedures, or failure of noninvasive support.

Correct endotracheal tube size and position are critical. A tube that advances too far can enter a mainstem bronchus and ventilate only one lung, while accidental extubation can produce rapid deterioration.

Humidification is essential when an artificial airway bypasses the upper airway. Suctioning should remove obstructing secretions while minimizing hypoxemia, trauma, loss of lung volume, and unnecessary stimulation.

Children with tracheostomies require careful attention to humidification, secretion management, skin care, tube security, emergency replacement procedures, communication, and eventual decannulation when appropriate.

CPAP, High-Flow Therapy, and Noninvasive Ventilation

Continuous positive airway pressure provides distending pressure throughout the respiratory cycle while allowing spontaneous breathing. CPAP increases functional residual capacity, helps stabilize alveoli, reduces intrapulmonary shunting, and can improve oxygenation while decreasing work of breathing.

It is especially important in premature infants with respiratory distress syndrome. Nasal CPAP can help avoid endotracheal intubation when the infant is breathing adequately but requires additional support to maintain lung expansion and oxygenation.

Bubble CPAP, ventilator-generated CPAP, and specialized infant flow systems are commonly used approaches.

High-flow nasal cannula delivers heated, humidified gas at increased flow rates. It can improve oxygen delivery, reduce inspiratory resistance, wash out upper-airway dead space, and decrease work of breathing. Some distending pressure may develop, although this pressure is not controlled as precisely as with CPAP.

Noninvasive positive-pressure ventilation provides inspiratory support above baseline positive airway pressure and may be useful in selected patients with acute or chronic respiratory insufficiency, neuromuscular weakness, obstructive sleep apnea, or other disorders.

The response must be assessed continuously. Persistent hypoxemia, rising carbon dioxide, worsening acidosis, increasing work of breathing, apnea, altered consciousness, or exhaustion may indicate that noninvasive support is failing and invasive ventilation should be considered.

Surfactant Replacement Therapy

Exogenous surfactant is commonly used in premature infants with respiratory distress syndrome. By reducing alveolar surface tension, surfactant increases compliance, improves alveolar stability, and can rapidly improve oxygenation and ventilation.

The medication is delivered directly into the trachea. Improvement may occur quickly, so ventilator pressures and inspired oxygen should be reassessed soon after administration.

If the same peak inspiratory pressure is continued after lung compliance improves, tidal volume may become excessive and increase the risk of volutrauma or air leak.

Surfactant therapy is most effective when combined with a broader strategy that limits unnecessary invasive ventilation and uses appropriate oxygen concentrations, CPAP, and lung-protective ventilator settings.

Invasive Mechanical Ventilation

Mechanical ventilation is required when a neonate or child cannot maintain adequate oxygenation, ventilation, or airway protection despite less invasive support.

Possible indications include severe respiratory distress syndrome, apnea, acute respiratory distress syndrome, severe asthma, bronchiolitis with respiratory failure, neurological impairment, neuromuscular weakness, shock, severe airway disease, and postoperative respiratory failure.

Pressure, Volume, and Time Constants

Neonatal ventilators may provide pressure-controlled, volume-targeted, synchronized, or hybrid modes.

With pressure-controlled ventilation, peak inspiratory pressure is set while tidal volume changes according to compliance and resistance. If lung compliance improves, the same pressure may produce a larger tidal volume. If compliance worsens, delivered volume may decrease.

Volume-targeted ventilation attempts to deliver a predetermined tidal volume while allowing pressure to vary according to respiratory mechanics.

Time constants are especially important in pediatric ventilation. A time constant is determined by resistance and compliance.

Stiff lungs with low compliance, such as those seen in respiratory distress syndrome, have relatively short time constants and tend to fill and empty quickly.

Obstructive diseases with increased airway resistance have longer time constants. Asthma and meconium aspiration can therefore require longer expiratory periods to reduce incomplete exhalation, dynamic hyperinflation, and auto-PEEP.

Preventing Ventilator-Induced Lung Injury

Excessive pressure, excessive volume, repeated alveolar collapse and reopening, and high oxygen exposure can all injure developing lungs. Lung-protective strategies focus on adequate gas exchange while limiting unnecessary airway pressure and overdistention.

Monitoring includes the patient’s appearance, chest movement, blood gases, oxygen saturation, tidal volume, airway pressure, ventilator waveforms, and patient-ventilator synchrony.

Ventilator graphics may reveal airway obstruction, air trapping, decreased compliance, ineffective triggering, leakage, or overdistention.

High-Frequency Ventilation

High-frequency ventilation uses very small tidal volumes delivered at much faster frequencies than conventional ventilation.

High-frequency oscillatory ventilation is used in selected neonatal and pediatric patients with severe lung disease, air leak syndromes, or inadequate gas exchange during conventional ventilation.

Its controls differ from conventional ventilation. Mean airway pressure plays an important role in lung recruitment and oxygenation. Amplitude influences the size of oscillatory pressure changes and therefore affects carbon dioxide elimination.

Increasing amplitude generally improves ventilation and lowers PaCO₂. Decreasing oscillatory frequency can increase the volume moved with each oscillation and may also improve carbon dioxide removal.

Note: Because these relationships differ from conventional ventilation, HFOV requires careful monitoring and familiarity with the specific ventilator system.

Inhaled Nitric Oxide, Heliox, and ECMO

Inhaled nitric oxide is a selective pulmonary vasodilator. Because it reaches ventilated lung regions, it can reduce pulmonary vascular resistance while improving ventilation-perfusion matching.

It is used primarily in selected term and near-term newborns with severe hypoxemic respiratory failure associated with pulmonary hypertension. Methemoglobin and nitrogen dioxide exposure should be monitored during treatment, and nitric oxide should be withdrawn gradually to reduce the risk of rebound pulmonary hypertension.

Heliox is a mixture of helium and oxygen. Its lower density can reduce resistance during turbulent airflow and may temporarily decrease work of breathing in selected cases of severe airway obstruction.

Extracorporeal membrane oxygenation, or ECMO, provides temporary extracorporeal gas exchange when severe but potentially reversible respiratory or cardiorespiratory failure cannot be adequately managed using conventional therapy.

Venovenous ECMO primarily supports the lungs. Venoarterial ECMO supports both respiratory and cardiovascular function. ECMO requires anticoagulation and intensive monitoring. Important complications include bleeding, thrombosis, neurological injury, infection, cannula problems, and mechanical failure of the extracorporeal circuit.

Major Neonatal Respiratory Disorders

Respiratory Distress Syndrome

Neonatal respiratory distress syndrome primarily affects premature infants because of inadequate surfactant production. Surfactant deficiency increases alveolar surface tension, leading to atelectasis, poor lung compliance, intrapulmonary shunting, hypoxemia, and increased work of breathing.

Typical findings include tachypnea, grunting, nasal flaring, retractions, cyanosis, and diminished breath sounds. Chest imaging commonly demonstrates low lung volumes, diffuse reticulogranular or ground-glass opacities, and air bronchograms.

Treatment may include antenatal corticosteroids when premature delivery is anticipated, early CPAP, careful oxygen therapy, exogenous surfactant, thermal support, and mechanical ventilation when necessary.

Transient Tachypnea of the Newborn

Transient tachypnea results from delayed absorption of fetal lung fluid. It generally presents shortly after birth with tachypnea and mild to moderate respiratory distress.

The condition usually improves as lung fluid is absorbed. Treatment is primarily supportive and may include oxygen or noninvasive respiratory support depending on the severity of symptoms.

Meconium Aspiration Syndrome

Meconium aspiration syndrome occurs when meconium enters the airways and produces respiratory disease. Meconium may cause partial or complete airway obstruction, chemical pneumonitis, surfactant dysfunction, atelectasis, air trapping, hypoxemia, and pulmonary vasoconstriction.

Severe disease may be complicated by PPHN. Respiratory support must provide adequate gas exchange while avoiding excessive pressure and air trapping. Some patients require mechanical ventilation, surfactant therapy, inhaled pulmonary vasodilators, or ECMO.

Apnea of Prematurity

Apnea of prematurity results primarily from immature respiratory control. Management may include tactile stimulation, positioning, continuous cardiorespiratory monitoring, caffeine therapy, CPAP, high-flow therapy, or positive-pressure ventilation depending on severity and frequency.

Persistent apnea requires evaluation for alternative causes rather than automatically assuming prematurity is responsible.

Bronchopulmonary Dysplasia

Bronchopulmonary dysplasia is a chronic lung disorder associated primarily with premature birth and prolonged respiratory support. Its development reflects a combination of immature lung structure, inflammation, oxygen exposure, mechanical ventilation, infection, and altered postnatal lung growth.

Management focuses on minimizing further lung injury while supporting growth and gas exchange. Strategies may include supplemental oxygen, nutritional support, careful fluid management, diuretics in selected patients, bronchodilators when appropriate, and noninvasive or invasive respiratory support.

Air Leak Syndromes

Pneumothorax, pulmonary interstitial emphysema, and other air leaks may develop spontaneously or as complications of positive-pressure ventilation. A tension pneumothorax can rapidly impair both ventilation and venous return and requires urgent recognition and treatment.

Congenital Disorders and Congenital Heart Disease

Congenital abnormalities may compromise the airway, lung development, pulmonary circulation, or cardiovascular system. Choanal atresia can obstruct the nasal airway, which is particularly important because young infants preferentially breathe through the nose.

Pierre Robin sequence may involve micrognathia and posterior displacement of the tongue, producing upper-airway obstruction. Esophageal atresia and tracheoesophageal fistula interfere with feeding and increase aspiration risk.

Congenital diaphragmatic hernia allows abdominal organs to enter the thoracic cavity. Compression of the developing lungs can cause severe pulmonary hypoplasia and pulmonary hypertension. Respiratory stabilization is required before surgical repair.

Congenital cardiac defects can also have major respiratory consequences. Lesions include atrial and ventricular septal defects, patent ductus arteriosus, atrioventricular septal defects, coarctation of the aorta, tetralogy of Fallot, transposition of the great arteries, pulmonary atresia, truncus arteriosus, and hypoplastic left heart syndrome.

Some defects increase pulmonary blood flow, while others restrict it or depend on a patent ductus arteriosus for adequate systemic or pulmonary circulation.

For this reason, oxygen and ventilation must be used with an understanding of the underlying cardiac anatomy. In ductal-dependent lesions, prostaglandin E1 may be used to maintain ductal patency until definitive intervention is available.

Major Pediatric Respiratory Disorders

Croup

Croup, or laryngotracheobronchitis, is most commonly a viral upper-airway illness in young children. Inflammation and edema occur primarily in the subglottic region. Typical symptoms include a barking cough, hoarseness, and inspiratory stridor, often following symptoms of an upper respiratory infection.

Increasing retractions, tachypnea, agitation, diminished air movement, cyanosis, lethargy, or altered mental status suggest progressively severe obstruction.

Treatment commonly includes corticosteroids. Nebulized epinephrine can temporarily reduce airway swelling in moderate to severe disease. Oxygen is administered when hypoxemia is present, and heliox may occasionally be considered as an adjunct in significant obstruction.

A child with progressive respiratory failure may require controlled airway management and mechanical ventilation.

Epiglottitis

Epiglottitis is an acute inflammatory condition affecting the epiglottis and surrounding supraglottic tissues. Severe swelling can rapidly obstruct the upper airway. Symptoms may include abrupt high fever, severe sore throat, difficulty swallowing, drooling, muffled voice, stridor, and respiratory distress. Children may prefer to sit upright and lean forward.

Unnecessary agitation and airway manipulation should be avoided when epiglottitis is suspected because complete obstruction can occur.

The airway should be managed in a controlled setting by clinicians prepared for advanced airway intervention. Once the airway is secure, antimicrobial therapy and other supportive treatment can be provided.

Bronchiolitis

Bronchiolitis primarily affects infants and young children and is commonly caused by respiratory syncytial virus. Inflammation, edema, mucus, and cellular debris narrow the small airways, producing wheezing, crackles, air trapping, increased work of breathing, and occasionally atelectasis.

Treatment is predominantly supportive. Oxygen is provided for clinically important hypoxemia, hydration is maintained, and nasal suctioning may improve breathing and feeding in infants with substantial upper-airway secretions.

Routine use of bronchodilators or corticosteroids is generally not necessary for uncomplicated bronchiolitis. Patients with apnea, progressive respiratory distress, exhaustion, or worsening gas exchange require closer monitoring and escalation of respiratory support.

Childhood Asthma

Asthma is characterized by chronic airway inflammation, bronchial hyperresponsiveness, and variable airflow obstruction. Symptoms may include recurrent wheezing, coughing, dyspnea, chest tightness, nighttime symptoms, and exercise limitation.

Spirometry may demonstrate a reduced FEV₁/FVC ratio and improvement following bronchodilator administration. Bronchoprovocation testing can help identify airway hyperresponsiveness when baseline spirometry is normal.

Long-term management focuses on controlling airway inflammation, reducing symptoms and exacerbations, maintaining normal activity, and minimizing treatment-related adverse effects.

Inhaled corticosteroids are important controller medications for persistent asthma. Bronchodilators are used for rapid relief of acute bronchoconstriction.

A severe exacerbation requires rapid evaluation of respiratory effort, oxygenation, airflow, mental status, and fatigue. A rising PaCO₂ in a child who remains in significant distress can indicate worsening ventilatory failure rather than improvement.

Mechanical ventilation, when necessary, should allow sufficient expiratory time to limit dynamic hyperinflation and air trapping.

Cystic Fibrosis

Cystic fibrosis is an inherited disorder involving abnormal CFTR protein function. Abnormal chloride and water transport produces thick secretions in the respiratory and gastrointestinal systems.

Respiratory manifestations include chronic productive cough, recurrent infection, bronchiectasis, wheezing, crackles, sinus disease, and progressive loss of pulmonary function. Diagnosis may involve newborn screening, sweat chloride testing, and genetic analysis.

Respiratory management can include airway clearance, exercise, bronchodilators when indicated, dornase alfa, hypertonic saline, inhaled or systemic antimicrobial therapy, and CFTR-modulating medications in eligible patients.

Nutrition is equally important because pancreatic insufficiency and malabsorption may contribute to poor growth. Long-term management therefore requires multidisciplinary respiratory, nutritional, gastrointestinal, and psychosocial care.

Foreign-Body Aspiration

Foreign-body aspiration should be considered when a previously healthy child develops sudden coughing, choking, respiratory distress, or localized airway findings. A bronchial foreign body may produce unilateral wheezing or diminished breath sounds. Many aspirated foods and plastic objects are radiolucent, so a normal standard radiograph does not exclude aspiration.

Complete obstruction requires immediate age-appropriate choking interventions. Blind finger sweeps should be avoided. Persistent suspected airway foreign bodies generally require bronchoscopic evaluation and removal.

Acute Lung Injury, Pleural Disease, and Neuromuscular Failure

Pediatric acute respiratory distress syndrome causes inflammatory injury to the alveolar-capillary membrane, impaired oxygenation, reduced lung compliance, and diffuse pulmonary abnormalities.

Mechanical ventilation may be required, with emphasis on lung-protective tidal volumes, appropriate PEEP, controlled oxygen exposure, and avoidance of excessive airway pressure.

Pleural disorders include pneumothorax, pleural effusion, hemothorax, and pneumomediastinum. Significant collections of air or fluid can interfere with lung expansion and may require thoracic drainage.

Neurological and neuromuscular diseases can cause respiratory failure by reducing ventilatory drive, weakening respiratory muscles, impairing cough, or compromising airway protection. Support may include assisted coughing, airway clearance, noninvasive ventilation, nocturnal respiratory support, or long-term invasive ventilation depending on disease severity.

Pediatric Pulmonary Function Testing

Pulmonary function testing must be adapted to the child’s developmental ability. Infants cannot voluntarily perform conventional spirometry, so specialized methods are required. Passive measurements can evaluate tidal volume, respiratory rate, minute ventilation, respiratory-system compliance, resistance, and time constants.

Rapid thoracoabdominal compression can generate forced expiration in infants. Because infants may empty much of their vital capacity in less than one second, measurements such as FEV₀.₅ or FEV₀.₇₅ may be used instead of FEV₁.

As children mature, conventional spirometry becomes increasingly practical. Coaching must be age appropriate, and useful information can sometimes be obtained even when a young child cannot satisfy every adult technical standard.

Obstructive disease typically causes reduced expiratory flow and a decreased FEV₁/FVC ratio. The expiratory portion of the flow-volume loop may appear concave.

Restriction is associated with reduced lung volumes. FVC may be decreased while the FEV₁/FVC ratio remains normal or increased. Measurement of total lung capacity is required to confirm a restrictive ventilatory defect.

Body plethysmography can measure thoracic gas volume, including trapped gas. Helium dilution and nitrogen washout may underestimate lung volume when severe airway obstruction prevents gas from communicating freely with all regions of the lung.

Impulse oscillometry can evaluate respiratory resistance with minimal patient cooperation and may be particularly useful in young children.

Bronchial challenge testing can assess airway hyperresponsiveness, while exercise testing can help reproduce exercise-related symptoms. Exhaled nitric oxide may provide information about eosinophilic airway inflammation and can assist with selected asthma evaluations.

Transport and Home Respiratory Care

Critically ill neonates and children may need transport to specialized centers. Successful transport depends on stabilization before departure whenever possible.

The transport team must anticipate airway problems, oxygen requirements, ventilation, temperature control, vascular access, medications, monitoring, equipment reliability, and the possibility of deterioration during movement.

Air transport introduces additional concerns involving altitude, atmospheric pressure, gas expansion, vibration, noise, and limited working space.

When possible, transferring a high-risk pregnant patient to a facility capable of neonatal intensive care before delivery is preferable to transporting a critically ill newborn afterward.

Children with chronic respiratory disease may also require complex treatment at home. Home therapies can include oxygen, pulse oximetry, suctioning, airway clearance, tracheostomy care, feeding support, noninvasive ventilation, and invasive mechanical ventilation.

Before discharge, caregivers should demonstrate competence with the equipment and emergency procedures. Families of ventilator-dependent children need to understand ventilator alarms, suctioning, tracheostomy emergencies, backup power, oxygen safety, infection prevention, and indications for seeking urgent medical assistance.

Quality and Safety in Pediatric Respiratory Care

Children are particularly vulnerable to preventable medical errors because equipment sizes, medications, tidal volumes, oxygen delivery, and many other treatments depend on weight and developmental stage. Careful verification and standardized processes are therefore essential.

Safe care includes accurate communication during handoffs, clear documentation of respiratory support, careful medication calculations, equipment checks, appropriate alarm settings, and early recognition of changing clinical status.

Quality improvement methods such as Plan-Do-Study-Act cycles, root cause analysis, Failure Modes and Effects Analysis, Lean principles, and Six Sigma approaches can be used to identify system weaknesses and reduce preventable harm.

Note: A strong safety culture encourages clinicians to report errors and near misses, identify hazards, communicate concerns, and improve the systems surrounding patient care.

Neonatal and Pediatric Care Practice Questions

1. What are the five major stages of fetal lung development?
The five major stages of fetal lung development are the embryonic, pseudoglandular, canalicular, saccular, and alveolar stages.

2. During which stage of fetal lung development do Type I and Type II pneumocytes begin to appear?
Type I and Type II pneumocytes begin to appear during the canalicular stage.

3. What is the primary function of pulmonary surfactant?
Pulmonary surfactant reduces surface tension within the alveoli, helping prevent alveolar collapse and improving lung compliance.

4. Which cells are primarily responsible for producing pulmonary surfactant?
Type II pneumocytes are primarily responsible for producing pulmonary surfactant.

5. Why is surfactant deficiency particularly important in premature infants?
Surfactant deficiency increases alveolar surface tension, promotes atelectasis, decreases lung compliance, and contributes to neonatal respiratory distress syndrome.

6. What are the three major fetal circulatory shunts?
The three major fetal circulatory shunts are the ductus venosus, foramen ovale, and ductus arteriosus.

7. Why is pulmonary vascular resistance high before birth?
Pulmonary vascular resistance is high because the fetal lungs are fluid-filled, unexpanded, and relatively hypoxic.

8. What happens to pulmonary vascular resistance when a newborn begins breathing?
Pulmonary vascular resistance decreases as the lungs expand and alveolar oxygen levels increase.

9. What causes functional closure of the foramen ovale after birth?
Functional closure occurs when left atrial pressure becomes greater than right atrial pressure after pulmonary blood flow increases.

10. What is persistent pulmonary hypertension of the newborn?
Persistent pulmonary hypertension of the newborn is a condition in which pulmonary vascular resistance remains abnormally elevated after birth, allowing right-to-left shunting and causing severe hypoxemia.

11. Which extremity is typically used to obtain a preductal oxygen saturation measurement in a newborn?
The right hand is typically used to obtain a preductal oxygen saturation measurement.

12. What five clinical components are evaluated with the Apgar score?
The Apgar score evaluates heart rate, respiratory effort, muscle tone, reflex irritability, and color.

13. What are common signs of respiratory distress in a newborn?
Common signs include tachypnea, nasal flaring, retractions, expiratory grunting, cyanosis, abnormal breath sounds, and chest-abdominal asynchrony.

14. Why does a newborn with respiratory distress produce an expiratory grunt?
Expiratory grunting creates positive pressure during expiration, which helps maintain end-expiratory lung volume and reduce alveolar collapse.

15. How is clinically significant apnea generally defined in a premature infant?
Clinically significant apnea is generally defined as a respiratory pause of approximately 20 seconds or a shorter pause associated with bradycardia, oxygen desaturation, cyanosis, pallor, or hypotonia.

16. What is the primary respiratory problem in neonatal respiratory distress syndrome?
The primary problem is inadequate pulmonary surfactant, which causes alveolar collapse, decreased lung compliance, hypoxemia, and increased work of breathing.

17. What respiratory support is commonly used early in premature infants with respiratory distress syndrome who continue to breathe spontaneously?
Nasal continuous positive airway pressure, or CPAP, is commonly used in premature infants with respiratory distress syndrome who are still breathing spontaneously.

18. How does CPAP improve respiratory function in neonates?
CPAP helps keep alveoli open, increases functional residual capacity, reduces intrapulmonary shunting, improves oxygenation, and may decrease work of breathing.

19. Why must ventilator settings be reassessed shortly after exogenous surfactant administration?
Lung compliance and oxygenation may improve rapidly after surfactant administration, so previously appropriate ventilator pressures and oxygen concentrations may become excessive.

20. What is the primary cause of transient tachypnea of the newborn?
Transient tachypnea of the newborn is primarily caused by delayed clearance of fetal lung fluid.

21. Why is meconium aspiration syndrome associated with an increased risk of air trapping?
Meconium can partially obstruct the airways and increase airway resistance, slowing exhalation and promoting incomplete lung emptying and air trapping.

22. What ventilator strategy is especially important in a child with severe asthma to reduce dynamic hyperinflation?
A sufficiently long expiratory time is important, usually achieved by using a lower respiratory rate, shorter inspiratory time, and adequate expiratory flow time.

23. What does a rising PaCO₂ suggest in a child who remains in severe respiratory distress from asthma?
A rising PaCO₂ may indicate respiratory muscle fatigue and impending ventilatory failure.

24. What clinical finding should raise particular suspicion for foreign-body aspiration in a child?
Sudden respiratory symptoms accompanied by unilateral wheezing or localized decreased breath sounds should raise suspicion for foreign-body aspiration.

25. Why must oxygen therapy be carefully controlled in premature infants?
Premature infants are vulnerable to oxygen-related injury, including oxidative lung damage and retinopathy of prematurity, so oxygen should be carefully titrated to provide adequate oxygenation without unnecessary hyperoxia.

26. What is the purpose of the Silverman-Anderson score in neonatal care?
The Silverman-Anderson score is used to quantify the severity of respiratory distress in a newborn by evaluating chest movement, retractions, nasal flaring, and expiratory grunting.

27. Why is preventing hypothermia especially important in newborns?
Preventing hypothermia is important because cold stress increases oxygen and glucose consumption, which can worsen metabolic and respiratory stress.

28. How can antenatal corticosteroids benefit a fetus when premature delivery is expected?
Antenatal corticosteroids accelerate fetal lung maturation and can reduce the severity of respiratory complications associated with prematurity.

29. What fetal heart-rate pattern is commonly associated with umbilical cord compression?
Variable decelerations are commonly associated with umbilical cord compression.

30. What fetal heart-rate pattern may indicate uteroplacental insufficiency?
Late decelerations may indicate uteroplacental insufficiency.

31. What is pulmonary hypoplasia?
Pulmonary hypoplasia is incomplete development of the lungs, resulting in reduced lung size, complexity, or gas-exchange capacity.

32. How does high-flow nasal cannula support an infant or child with respiratory distress?
High-flow nasal cannula delivers heated, humidified gas that can improve oxygen delivery, reduce work of breathing, wash out upper-airway dead space, and provide some distending pressure.

33. What is one major difference between CPAP and high-flow nasal cannula?
CPAP provides a controlled level of continuous positive airway pressure, while the distending pressure produced by high-flow nasal cannula is less precisely controlled.

34. What findings may indicate that noninvasive ventilation is failing?
Persistent hypoxemia, rising carbon dioxide, worsening acidosis, increasing work of breathing, apnea, fatigue, or altered mental status may indicate failure of noninvasive ventilation.

35. Why are small airway changes especially important in infants and young children?
Because their airways are already narrow, even a small amount of edema, mucus, inflammation, or bronchoconstriction can cause a large increase in airflow resistance.

36. Why can crying reduce the effectiveness of aerosol therapy in an infant?
Crying alters the breathing pattern, increases mask leaks, and promotes aerosol deposition on the face and upper airway rather than in the lungs.

37. Which aerosol delivery devices are commonly useful for young children who cannot coordinate inhalation?
Nebulizers and pressurized metered-dose inhalers used with spacers or valved holding chambers are commonly useful for young children.

38. Why are dry powder inhalers generally more appropriate for older cooperative children?
Dry powder inhalers require the patient to generate an adequate inspiratory flow and perform a coordinated inhalation maneuver.

39. What is the advantage of a vibrating-mesh nebulizer during mechanical ventilation?
A vibrating-mesh nebulizer can generate aerosol without adding external gas flow to the ventilator circuit, reducing the risk of altering delivered volume, pressure, PEEP, or triggering.

40. Why is humidification essential when a child has an artificial airway?
An artificial airway bypasses the upper airway’s normal warming and humidifying functions, so added humidification is necessary to prevent drying and thickening of secretions.

41. What is the main purpose of airway clearance therapy?
The main purpose of airway clearance therapy is to mobilize and remove secretions when the patient’s cough or mucociliary clearance is inadequate.

42. What is a major concern if an endotracheal tube advances too far in a pediatric patient?
The tube may enter a mainstem bronchus, causing preferential ventilation of one lung and inadequate ventilation of the other.

43. How does body plethysmography differ from gas-dilution methods when measuring lung volumes?
Body plethysmography can measure trapped thoracic gas, while helium dilution and nitrogen washout may underestimate lung volume when poorly ventilated regions do not communicate well with the airways.

44. Why is FEV₁ often not useful in infant pulmonary function testing?
Infants can empty much of their vital capacity in less than one second, so shorter measurements such as FEV₀.₅ or FEV₀.₇₅ are often more useful.

45. What pulmonary function pattern is generally associated with obstructive disease?
Obstructive disease generally produces reduced expiratory airflow and a decreased FEV₁/FVC ratio.

46. What pulmonary function pattern is generally associated with restrictive disease?
Restrictive disease generally produces reduced lung volumes, with a decreased FVC and a normal or increased FEV₁/FVC ratio.

47. What is impulse oscillometry used to assess in pediatric patients?
Impulse oscillometry is used to assess respiratory-system resistance and mechanics with minimal patient cooperation.

48. What is the primary respiratory problem in congenital diaphragmatic hernia?
Abdominal organs enter the thoracic cavity and compress the developing lungs, which can cause pulmonary hypoplasia and pulmonary hypertension.

49. What is the difference between venovenous and venoarterial ECMO?
Venovenous ECMO primarily provides respiratory support, while venoarterial ECMO provides both respiratory and cardiovascular support.

50. What is the primary action of inhaled nitric oxide in neonatal respiratory care?
Inhaled nitric oxide acts as a selective pulmonary vasodilator, lowering pulmonary vascular resistance in ventilated lung regions and potentially improving oxygenation.

51. What role does the ductus arteriosus play in fetal circulation?
The ductus arteriosus allows most blood from the pulmonary artery to bypass the high-resistance fetal lungs and flow into the aorta.

52. What role does the ductus venosus play in fetal circulation?
The ductus venosus allows a portion of oxygenated umbilical venous blood to bypass the liver and enter the inferior vena cava.

53. What happens to systemic vascular resistance when the umbilical cord is clamped?
Systemic vascular resistance increases because the low-resistance placental circulation is removed.

54. What is the primary purpose of fetal lung fluid before birth?
Fetal lung fluid helps maintain lung expansion and supports normal pulmonary growth and development.

55. What maternal condition can delay fetal surfactant maturation and increase the risk of neonatal respiratory distress?
Maternal diabetes can increase the risk of neonatal respiratory distress by contributing to delayed fetal lung maturation.

56. What is bronchopulmonary dysplasia?
Bronchopulmonary dysplasia is a chronic lung disorder of premature infants associated with immature lung development, inflammation, oxygen exposure, and prolonged respiratory support.

57. What is the main cause of apnea of prematurity?
Apnea of prematurity primarily results from immaturity of the respiratory control centers.

58. Which medication is commonly used to reduce recurrent apnea of prematurity?
Caffeine is commonly used to stimulate respiratory drive and reduce episodes of apnea of prematurity.

59. Why should other causes be excluded before diagnosing apnea of prematurity?
Conditions such as infection, hypoxemia, anemia, seizures, metabolic abnormalities, and medication effects can also cause apnea and may require different treatment.

60. What is the typical radiographic appearance of neonatal respiratory distress syndrome?
Chest imaging typically shows low lung volumes, diffuse ground-glass or reticulogranular opacities, and air bronchograms.

61. How does respiratory distress syndrome affect the respiratory system time constant?
Respiratory distress syndrome produces a short time constant because lung compliance is reduced while airway resistance is relatively normal.

62. How does meconium aspiration syndrome affect the respiratory system time constant?
Meconium aspiration syndrome tends to produce a longer time constant because airway resistance is increased, making lung emptying slower.

63. What ventilator variable is especially important for oxygenation during high-frequency oscillatory ventilation?
Mean airway pressure is especially important for lung recruitment and oxygenation during high-frequency oscillatory ventilation.

64. What adjustment during high-frequency oscillatory ventilation can improve carbon dioxide removal?
Increasing amplitude can increase oscillatory tidal volume and improve carbon dioxide elimination.

65. How can decreasing frequency during high-frequency oscillatory ventilation affect ventilation?
Decreasing frequency can increase the volume moved with each oscillation and improve carbon dioxide removal.

66. What is a major advantage of volume-targeted neonatal ventilation?
Volume-targeted ventilation can provide a more consistent tidal volume while allowing airway pressure to change as compliance and resistance change.

67. What happens to tidal volume during pressure-controlled ventilation if lung compliance suddenly decreases?
Tidal volume decreases because the same preset inspiratory pressure produces less volume when the lungs become less compliant.

68. Why should neonatal ventilator circuits have low compliance and low compressible volume?
Neonatal tidal volumes are very small, so gas compressed within the circuit can represent a substantial portion of the intended delivered volume.

69. What is the main respiratory effect of croup?
Croup causes inflammation and edema of the subglottic upper airway, leading to barking cough, hoarseness, and inspiratory stridor.

70. What radiographic sign is classically associated with croup?
Subglottic narrowing may produce the characteristic steeple sign on imaging.

71. What clinical features help distinguish epiglottitis from croup?
Epiglottitis typically has a more abrupt onset with high fever, severe sore throat, dysphagia, drooling, and a preference for sitting upright.

72. Why should unnecessary airway examination be avoided in a child with suspected epiglottitis?
Airway manipulation can worsen obstruction and potentially precipitate complete airway closure.

73. What is the main treatment approach for uncomplicated bronchiolitis?
Treatment is primarily supportive and includes monitoring, hydration, nasal suctioning when needed, and supplemental oxygen for significant hypoxemia.

74. Why are bronchodilators not routinely recommended for every infant with bronchiolitis?
Much of the airflow obstruction in bronchiolitis results from edema, mucus, and cellular debris rather than reversible bronchospasm.

75. What is the primary defect in cystic fibrosis that leads to thick respiratory secretions?
Abnormal CFTR function disrupts chloride and water transport across epithelial cells, producing dehydrated, thick secretions that are difficult to clear.

76. What is the normal respiratory rate for a newborn?
A normal newborn respiratory rate is generally about 30–60 breaths per minute, although some references describe a typical range of approximately 40–60 breaths per minute.

77. What does head bobbing indicate in an infant?
Head bobbing indicates increased work of breathing caused by excessive use of the neck and accessory respiratory muscles.

78. What does inspiratory stridor usually suggest?
Inspiratory stridor usually suggests obstruction of the extrathoracic upper airway.

79. What can digital clubbing indicate in a pediatric patient?
Digital clubbing can suggest chronic disease such as cystic fibrosis, chronic hypoxemia, or certain congenital cardiac disorders.

80. What information does capnography provide in neonatal and pediatric respiratory care?
Capnography provides information about ventilation, respiratory rate, airway patency, endotracheal tube placement, and changes in pulmonary perfusion.

81. Why can a normal pulse oximetry reading fail to rule out respiratory failure?
Pulse oximetry assesses oxygen saturation but does not directly measure ventilation, so significant carbon dioxide retention can occur despite an acceptable SpO₂.

82. What is the purpose of bronchial provocation testing in children?
Bronchial provocation testing evaluates airway hyperresponsiveness and can help identify asthma when baseline spirometry is normal.

83. What does a negative methacholine challenge suggest?
A negative methacholine challenge makes clinically significant airway hyperresponsiveness and asthma less likely.

84. What does exhaled nitric oxide measurement help assess?
Exhaled nitric oxide can help assess eosinophilic airway inflammation and may assist in the evaluation and management of asthma.

85. What is the purpose of rapid thoracoabdominal compression testing in infants?
Rapid thoracoabdominal compression produces a forced expiratory maneuver in infants who cannot voluntarily perform conventional spirometry.

86. Why should pediatric pulmonary function results be interpreted with age-appropriate reference values?
Lung size and respiratory function change substantially with growth and development, so pediatric results must be compared with appropriate reference values for the child’s age and body size.

87. What is the nominal dose in aerosol therapy?
The nominal dose is the amount of medication initially placed into the aerosol delivery device.

88. What is meant by the lung dose of an aerosolized medication?
The lung dose is the portion of the aerosolized medication that actually reaches the trachea and lower respiratory tract.

89. Why is aerosol deposition generally lower in infants than in adults?
Infants have smaller tidal volumes, rapid breathing, narrow airways, nasal breathing, limited coordination, and greater medication loss in the upper airway and delivery system.

90. What is off-label medication use in pediatric respiratory care?
Off-label use occurs when a medication is given for an age group, indication, dose, dosage form, or route that is not specifically included in its approved labeling.

91. Why should airway clearance therapy not be prescribed automatically to every pediatric respiratory patient?
Airway clearance should have a specific clinical indication because it may provide little benefit when secretion retention or impaired clearance is not present.

92. What is the main purpose of a tracheostomy in a child with chronic respiratory needs?
A tracheostomy can provide a stable artificial airway for prolonged ventilation, airway protection, secretion management, or relief of upper-airway obstruction.

93. What should caregivers of a ventilator-dependent child understand before home discharge?
Caregivers should understand ventilator operation, alarms, suctioning, tracheostomy emergencies, backup power, oxygen safety, infection prevention, and when to seek medical assistance.

94. Why is stabilization important before transporting a critically ill infant or child?
Stabilization reduces the risk of deterioration during transport, where space, equipment access, personnel, and treatment options may be more limited.

95. How can altitude affect gas-filled spaces during air transport?
Reduced atmospheric pressure at altitude can cause trapped gases to expand, which may worsen conditions such as pneumothorax or increase gas volume in equipment and body cavities.

96. What is a tension pneumothorax?
A tension pneumothorax is progressive accumulation of pleural air under pressure that impairs lung expansion and can reduce venous return and cardiac output.

97. What is the purpose of a thoracostomy tube in a pediatric patient?
A thoracostomy tube is used to remove air or fluid from the pleural space so the lung can re-expand.

98. Why must oxygen therapy be used carefully in some children with congenital heart disease?
Oxygen can alter pulmonary vascular resistance and pulmonary blood flow, potentially disrupting the balance between pulmonary and systemic circulation in certain cardiac defects.

99. Why may prostaglandin E1 be administered to a newborn with a ductal-dependent congenital heart defect?
Prostaglandin E1 is used to maintain patency of the ductus arteriosus so adequate pulmonary or systemic blood flow can continue until definitive treatment is performed.

100. How is pulse oximetry used to help screen newborns for critical congenital heart disease?
Screening compares oxygen saturation from the right hand and a foot, and persistently low saturation or a significant preductal-postductal difference can prompt further cardiac evaluation.

Final Thoughts

Neonatal and pediatric respiratory care depends on understanding how respiratory physiology changes from fetal development through childhood and applying that knowledge to assessment and treatment. Prematurity, small airway size, high metabolic demand, immature ventilatory control, and developing lungs can make respiratory illness progress quickly.

Effective care requires careful monitoring, age-appropriate oxygen and aerosol delivery, appropriate airway support, lung-protective ventilation, and early recognition of treatment failure.

Whether managing a premature infant with respiratory distress syndrome or a child with asthma, croup, cystic fibrosis, or respiratory failure, therapy should support gas exchange while minimizing injury and addressing the underlying disorder.